What was the primary aim of the PREFER study?
To compare the efficacy of different GnRH agonist regimens in premenopausal breast cancer patients
To optimize oncofertility care by understanding patient needs toward fertility preservation and ovarian function preservation options
To evaluate pregnancy outcomes in young breast cancer survivors who underwent fertility preservation procedures